Nuveen’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Nuveen’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-113,312	Closed	-$326K	–	3567
2022 Q1	$326K	Buy	113,312 +205	+0.2%	+$718	﹤0.01%	3110
2021 Q4	$577K	Sell	113,107 -8,992	-7%	-$58K	﹤0.01%	3040
2021 Q3	$867K	Buy	122,099 +22,983	+23%	+$147K	﹤0.01%	3040
2021 Q2	$739K	Buy	+99,116	New	+$764K	﹤0.01%	3103

Other funds holding SURF

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nuveen's SURF Position: Q2 2022 in Review

Nuveen sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2022, closing a stake of 113,312 shares — an estimated $326K sold.

Nuveen first reported a position in SURF in Q2 2021 and held it in 4 quarters. The position peaked at $867K in Q3 2021. 84 funds tracked by Wall St. Rank hold SURF as of Q2 2022.

Nuveen reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Nuveen sold 113,312 Surface Oncology, Inc. Common Stock shares in Q2 2022, an estimated $326K.
Nuveen first reported a position in Surface Oncology, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
Nuveen's Surface Oncology, Inc. Common Stock position peaked at $867K in Q3 2021.
84 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.